DEUTSCHE BETEILIGUNGS AG (DBAN.DE) Stock Fundamental Analysis
Europe - FRA:DBAN - DE000A1TNUT7 - Common Stock
23.425 EUR
-0.12 (-0.53%)
Taking everything into account, DBAN scores 5 out of 10 in our fundamental rating. DBAN was compared to 112 industry peers in the Capital Markets industry. While DBAN has a great health rating, its profitability is only average at the moment. DBAN is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year DBAN was profitable.
DBAN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: DBAN reported negative net income in multiple years.
In multiple years DBAN reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.29%, DBAN belongs to the top of the industry, outperforming 80.36% of the companies in the same industry.
DBAN has a Return On Equity (8.26%) which is comparable to the rest of the industry.
DBAN has a Return On Invested Capital of 4.84%. This is in the better half of the industry: DBAN outperforms 68.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.29% | ||
| ROE | 8.26% | ||
| ROIC | 4.84% |
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 43.12%, DBAN belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
In the last couple of years the Profit Margin of DBAN has declined.
The Operating Margin of DBAN (45.95%) is better than 83.93% of its industry peers.
In the last couple of years the Operating Margin of DBAN has declined.
DBAN has a Gross Margin of 93.60%. This is amongst the best in the industry. DBAN outperforms 92.86% of its industry peers.
DBAN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 45.95% | ||
| PM (TTM) | 43.12% | ||
| GM | 93.6% |
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
2. Health
2.1 Basic Checks
The number of shares outstanding for DBAN has been reduced compared to 1 year ago.
DBAN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DBAN has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.83 indicates that DBAN is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of DBAN (2.83) is better than 76.79% of its industry peers.
The Debt to FCF ratio of DBAN is 4.14, which is a neutral value as it means it would take DBAN, 4.14 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DBAN (4.14) is better than 76.79% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that DBAN is not too dependend on debt financing.
DBAN has a Debt to Equity ratio of 0.20. This is in the better half of the industry: DBAN outperforms 70.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 4.14 | ||
| Altman-Z | 2.83 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
DBAN has a Current Ratio of 6.68. This indicates that DBAN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.68, DBAN belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
A Quick Ratio of 6.68 indicates that DBAN has no problem at all paying its short term obligations.
DBAN's Quick ratio of 6.68 is amongst the best of the industry. DBAN outperforms 92.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.68 | ||
| Quick Ratio | 6.68 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.70% over the past year.
The Earnings Per Share has been decreasing by -3.13% on average over the past years.
DBAN shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.52%.
Measured over the past years, DBAN shows a small growth in Revenue. The Revenue has been growing by 7.25% on average per year.
EPS 1Y (TTM)0.7%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%-70.3%
Revenue 1Y (TTM)22.52%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%-44.94%
3.2 Future
DBAN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -13.64% yearly.
Based on estimates for the next years, DBAN will show a decrease in Revenue. The Revenue will decrease by -4.39% on average per year.
EPS Next Y-64.98%
EPS Next 2Y-30.98%
EPS Next 3Y-13.64%
EPS Next 5YN/A
Revenue Next Year-22.08%
Revenue Next 2Y0.23%
Revenue Next 3Y-4.39%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 9.04, which indicates a very decent valuation of DBAN.
Based on the Price/Earnings ratio, DBAN is valued cheaper than 86.61% of the companies in the same industry.
DBAN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.20.
With a Price/Forward Earnings ratio of 9.93, the valuation of DBAN can be described as very reasonable.
Based on the Price/Forward Earnings ratio, DBAN is valued cheaply inside the industry as 88.39% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, DBAN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.04 | ||
| Fwd PE | 9.93 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DBAN indicates a rather cheap valuation: DBAN is cheaper than 83.04% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.78 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as DBAN's earnings are expected to decrease with -13.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-30.98%
EPS Next 3Y-13.64%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.26%, DBAN is a good candidate for dividend investing.
DBAN's Dividend Yield is a higher than the industry average which is at 6.14.
Compared to an average S&P500 Dividend Yield of 2.38, DBAN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.26% |
5.2 History
The dividend of DBAN decreases each year by -5.78%.
Dividend Growth(5Y)-5.78%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
DBAN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-30.98%
EPS Next 3Y-13.64%
FRA:DBAN (9/17/2025, 2:15:55 PM)
23.425
-0.12 (-0.53%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners13.1%
Inst Owner ChangeN/A
Ins Owners10%
Ins Owner ChangeN/A
Market Cap440.39M
Analysts89.23
Price Target39.55 (68.84%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.26% |
Yearly Dividend1.01
Dividend Growth(5Y)-5.78%
DP0%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.13%
PT rev (3m)-3.66%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-41.78%
EPS NY rev (3m)-41.78%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-13.07%
Revenue NY rev (3m)-10.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.04 | ||
| Fwd PE | 9.93 | ||
| P/S | 3.52 | ||
| P/FCF | 13.78 | ||
| P/OCF | 13.44 | ||
| P/B | 0.67 | ||
| P/tB | 0.73 | ||
| EV/EBITDA | N/A |
EPS(TTM)2.59
EY11.06%
EPS(NY)2.36
Fwd EY10.07%
FCF(TTM)1.7
FCFY7.26%
OCF(TTM)1.74
OCFY7.44%
SpS6.65
BVpS34.75
TBVpS32.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.29% | ||
| ROE | 8.26% | ||
| ROCE | 6.87% | ||
| ROIC | 4.84% | ||
| ROICexc | 5.19% | ||
| ROICexgc | 5.54% | ||
| OM | 45.95% | ||
| PM (TTM) | 43.12% | ||
| GM | 93.6% | ||
| FCFM | 25.55% |
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-35.11%
ROICexcg growth 5Y-7.26%
ROICexc growth 3Y-36.76%
ROICexc growth 5Y-8.68%
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
F-Score6
Asset Turnover0.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 4.14 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 59.24% | ||
| Current Ratio | 6.68 | ||
| Quick Ratio | 6.68 | ||
| Altman-Z | 2.83 |
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.7%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%-70.3%
EPS Next Y-64.98%
EPS Next 2Y-30.98%
EPS Next 3Y-13.64%
EPS Next 5YN/A
Revenue 1Y (TTM)22.52%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%-44.94%
Revenue Next Year-22.08%
Revenue Next 2Y0.23%
Revenue Next 3Y-4.39%
Revenue Next 5YN/A
EBIT growth 1Y14.61%
EBIT growth 3Y-35.63%
EBIT growth 5Y2.34%
EBIT Next Year-23.9%
EBIT Next 3Y0.97%
EBIT Next 5YN/A
FCF growth 1Y242.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y251.24%
OCF growth 3YN/A
OCF growth 5YN/A